Exor Capital LLP Ginkgo Bioworks Holdings, Inc. Transaction History

Exor Capital LLP

  • $3.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.06 - $1.67 $1.59 Million - $2.51 Million
1,500,000 Added 17.62%
10,011,301 $11.6 Million
Q4 2023

Feb 13, 2024
BUY
$1.26 - $1.79 $2.77 Million - $3.94 Million
2,200,000 Added 34.86%
8,511,301 $14.4 Million
Q2 2023

Aug 11, 2023
BUY
$1.14 - $1.95 $7.19 Million - $12.3 Million
6,311,301 New
6,311,301 $11.7 Million

Others Institutions Holding DNA

# of Institutions
43
Shares Held
48.4M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Exor Capital LLP Portfolio

Follow Exor Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exor Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Exor Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email